Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Date completed: 5/7/13 Type:
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury